glp-1 and kidney cancer Frontiers Renal effects of GLP-1 receptor

95% CI, 0.87-0.92)

Post-gastric bypass hypoglycaemia: a review

Government records from the United States (US) suggest that the condition affects ~29 million Americans of the ~133 million alcohol consumers within the country

However, this approach carries the inherent risk of heightened side effects and drug toxicity

The EMA directed Novo Nordisk to update product labels to indicate NAION as a rare side effect, defined as occurring in up to 1 in 10,000 users after at least one year of treatment

[2] [28] While these reports warrant attention, the absolute number remains small relative to the total number of patients treated, and causality has not been established